Anthrax Protective Antigen Cleavage and Clearance from the Blood of Mice and Rats
- 1 November 2007
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 75 (11) , 5175-5184
- https://doi.org/10.1128/iai.00719-07
Abstract
Bacillus anthracis protective antigen (PA) is an 83-kDa (PA83) protein that is cleaved to the 63-kDa protein (PA63) as an essential step in binding and internalizing lethal factor (LF). To assess in vivo receptor saturating PA concentrations, we injected mice with PA variants and measured the PA remaining in the blood at various times using PA83- and PA63-specific enzyme-linked immunosorbent assays. We found that both wild-type PA (WT-PA) and a receptor-binding-defective mutant (Ub-PA) were cleaved to PA63 independent of their ability to bind cells. This suggested a PA-acting protease activity in the blood. The protease cleaved PA at the furin cleavage sequence because furin site-modified PA mutants were not cleaved. Cleavage measured in vitro was leupeptin sensitive and dependent on calcium. Cell surface cleavage was important for toxin clearance, however, as Ub-PA and uncleavable PA mutants were cleared at slower rates than WT-PA. The cell binding-independent cleavage of PA was also verified by using Ub-PA (which is still cleaved) to rescue mice from toxin challenge by competitively binding circulating LF. This mutant was able to rescue mice even when given 12 h before toxin challenge. Its therapeutic ability was comparable to that of dominant-negative PA, which binds cells but does not allow LF translocation, and to the protection afforded through receptor clearance by WT-PA and uncleavable receptor binding-competent mutants. The PA cleavage and clearance observed in mice did not appear to have a role in the differential mouse susceptibility as it occurred similarly in lethal toxin (LT)-resistant DBA/2J and LT-sensitive BALB/cJ mice. Interestingly, PA63 was not found in LT-resistant or -sensitive rats and PA83 clearance was slower in rats than in mice. Finally, to determine the minimum amount of PA required in circulation for LT toxicity in mice, we administered time-separated injections of PA and LF and showed that lethality of LF for mice after PA was no longer measurable in circulation, suggesting active PA sequestration at tissue surfaces.Keywords
This publication has 33 references indexed in Scilit:
- Protective Antigen as a Correlative Marker for Anthrax in Animal ModelsInfection and Immunity, 2006
- Detection of Anthrax Toxin in the Serum of Animals Infected with Bacillus anthracis by Using Engineered ImmunoassaysClinical and Vaccine Immunology, 2006
- Purified Bacillus anthracis Lethal Toxin Complex Formed in Vitro and during Infection Exhibits Functional and Biological ActivityJournal of Biological Chemistry, 2005
- Alanine-scanning Mutations in Domain 4 of Anthrax Toxin Protective Antigen Reveal Residues Important for Binding to the Cellular Receptor and to a Neutralizing Monoclonal AntibodyJournal of Biological Chemistry, 2003
- Anthrax toxin triggers endocytosis of its receptor via a lipid raft–mediated clathrin-dependent processThe Journal of cell biology, 2003
- Identification of the cellular receptor for anthrax toxinNature, 2001
- Dominant-Negative Mutants of a Toxin Subunit: An Approach to Therapy of AnthraxScience, 2001
- Anthrax Lethal Factor Cleaves the N-Terminus of MAPKKs and Induces Tyrosine/Threonine Phosphorylation of MAPKs in Cultured MacrophagesBiochemical and Biophysical Research Communications, 1998
- Proteolytic Inactivation of MAP-Kinase-Kinase by Anthrax Lethal FactorScience, 1998
- Serum protease cleavage of Bacillus anthracis protective antigenJournal of General Microbiology, 1992